Cargando…
Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer
We report the case of a 45-year-old woman with metastatic breast cancer who started treatment with alpelisib nine days before developing diabetic ketoacidosis (DKA). At the time of DKA diagnosis, blood tests showed a capillary blood glucose of 30 mmol/L, serum carbon dioxide level of 11 mmol/L, an a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799918/ https://www.ncbi.nlm.nih.gov/pubmed/35141074 http://dx.doi.org/10.7759/cureus.20817 |